ArticleWorld journal of gastroenterology2015
Retrospective analysis of extra-gastrointestinal stromal tumors.
Article in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 53 citations in OpenAlex.
- Clinicopathological characteristics and long-term prognosis of peritoneal and retroperitoneal gastrointestinal stromal tumors.Surgical endoscopy · 2025Article
- The first case of primary extragastrointestinal stromal tumor of the kidney: a case description.Quantitative imaging in medicine and surgery · 2025Article
- Domestic research on extra-gastrointestinal stromal tumors: A ten-year review.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025Review
- Trends and Financial Burden of Gastrointestinal Stromal Tumors in the United States: A Comprehensive Analysis of United States Hospitalizations.Gastroenterology research · 2025Article
- Computed tomography-based contrast features for distinguishing extra-gastrointestinal stromal tumors from intra-abdominal fibromatosis.Diagnostic and interventional radiology (Ankara, Turkey) · 2025Article
- Establishment and validation of a prognostic nomogram for extra-gastrointestinal stromal tumors.Frontiers in oncology · 2025Article
- Case report: Clinical and molecular features of renal gastrointestinal tumor.Frontiers in oncology · 2025Article
- Article
- Article
- Extragastrointestinal stromal tumour of the transverse mesocolon mimicking giant ovarian cystic neoplasm.BMJ case reports · 2023Article
- Multiple Metastatic Extra-gastrointestinal Stromal Tumors with Plasmoid Differentiation: A Case Report and Review of Literature.Internal medicine (Tokyo, Japan) · 2023Review
- Article
- Primary Extragastrointestinal Stromal Tumor of Greater Omentum with Intraperitoneal Bleeding.Internal medicine (Tokyo, Japan) · 2021Article
- Curative intent treatment of late presented extragastrointestinal stromal tumor: two identical case reports with literature review.Journal of surgical case reports · 2021Article
- Current knowledge of primary prostatic extra-gastrointestinal stromal tumor: a case report and review of the literature.The Journal of international medical research · 2021Review
- Clinical Features of Extragastrointestinal Stromal Tumor Compared with Gastrointestinal Stromal Tumor: A Retrospective, Multicenter, Real-World Study.Journal of oncology · 2021Article
- Perianal extragastrointestinal stromal tumor.Korean journal of clinical oncology · 2020Article
- Primary extra-gastrointestinal stromal tumor (EGIST) of the mesentery: Case report and review of literature.Annals of medicine and surgery (2012) · 2020Article
- Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors.World journal of gastroenterology · 2020Review
- Retroperitoneal gastrointestinal stromal tumor: A case report and literature review.Radiology case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate the clinicopathologic features of patients with extra-gastrointestinal stromal tumors (EGISTs) in South Korea.
methodsA total of 51 patients with an EGIST were identified. The clinicopathologic features, including sex, age, location, tumor size, histology, mitotic rate, immunohistochemical features, genetic status and survival data, were analyzed.
resultsThe median age was 55 years (range: 29-80 years), and male:female ratio was 1:1.04. The most common site was in the mesentery (n = 15) followed by the retroperitoneum (n = 13) and omentum (n = 8). The median tumor size was 9.0 cm (range: 2.6-30.0 cm) and the median mitotic rate was 5.0/50HPF. (1/50 - 185/50). KIT was analyzed in 16, which revealed 10 cases with wild-type KIT and 6 cases with an exon 11 mutation. Among 51 patients, 31 patients had undergone surgery, and 10 had unresectable disease and had taken palliative imatinib, which resulted in 22.7 mo of progression-free survival. Of the patients who had undergone surgery, 18 did not take adjuvant imatinib, and 8 of these were categorized as "high risk" according to the risk criteria. However, the relapse-free survival was not different (P = 0.157) between two groups.
conclusionBecause the biologic behaviors of GISTs differ according to the location of the tumor, a more stratified strategy is required for managing EGISTs including incorporation of molecular features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.